Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

ClinicalTrials.gov ID: NCT01503021

Public ClinicalTrials.gov record NCT01503021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of representative adult chronic kidney disease patients on hemodialysis (CKD-HD). The purpose of the extension study is to assess the long-term safety and tolerability of SFP.

Study identification

NCT ID
NCT01503021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
718 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2011 (Type not available)
Primary completion
Jan 2014 (Actual)
Completion
Jan 2014 (Actual)
Last update posted
Oct 25, 2016

2011 – 2014

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Not listed Mobile Alabama 36688 —
Not listed Northridge California 91324 —
Not listed Arvada Colorado 80002 —
Not listed Westminster Colorado 80031 —
Not listed Lauderhill Florida 33319 —
Not listed Marietta Georgia 30060 —
Not listed Chicago Illinois 60616 —
Not listed Peoria Illinois 61603 —
Not listed Columbus Indiana 47201 —
Not listed Wichita Kansas 67214 —
Not listed Baton Rouge Louisiana 70808 —
Not listed Shreveport Louisiana 71101 —
Not listed Camp Springs Maryland 20748 —
Not listed Gulfport Mississippi 39501 —
Not listed McComb Mississippi 39648 —
Not listed Tupelo Mississippi 38801 —
Not listed City of Saint Peters Missouri 63376 —
Not listed Lincoln Nebraska 68510 —
Not listed Reno Nevada 89511 —
Not listed Rocky Mount North Carolina 27804 —
Not listed Dayton Ohio 45428 —
Not listed Columbia South Carolina 29209 —
Research Across America Houston Texas 75234 —
Not listed Houston Texas 77051 —
Not listed Irving Texas 75061 —
Not listed Mission Texas 78572 —
Not listed Temple Texas 76508 —
Not listed Tyler Texas 75701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01503021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01503021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →